Ferring Pharmaceuticals launches Nocdurna in US to treat nocturia

pharmanewsdaily- November 10, 2018 0

Ferring Pharmaceuticals has announced the launch of Nocdurna (desmopressin acetate) in the United States, marking a significant advancement in the treatment of nocturia caused by ... Read More

FDA approves Serenity Pharmaceuticals’ Noctiva for nocturnal polyuria

pharmanewsdaily- March 5, 2017 0

Serenity Pharmaceuticals has received U.S. Food and Drug Administration (FDA) approval for Noctiva (desmopressin acetate), a nasal spray developed to treat nocturnal polyuria syndrome in ... Read More